Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial

This publication has 35 references indexed in Scilit:

• Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial
  American Heart Journal, 2006
• Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
  Circulation, 2006
• Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice
  Circulation, 2006
• Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
  American Heart Journal, 2006
• Predictors and 1-year outcome of major bleeding in patients with non–ST-elevation acute coronary syndromes: Insights from the Canadian Acute Coronary Syndrome Registries
  American Heart Journal, 2005
• Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary Syndromes
  The American Journal of Cardiology, 2005
• Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options
  Nature Clinical Practice Cardiovascular Medicine, 2005
• Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale
  American Heart Journal, 2004
• Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
  European Heart Journal, 2002
• Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
  Journal of Clinical Investigation, 1990